APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: The increase in CIGB-258 content accelerated the wound-healing activity of the apoA-I:CIGB-258 mixture with the least production of ROS and apoptosis under the presence of CML (Figure 6 and Figure 7).